| |
| |
|
| Insider
Information: |
Parsey Merdad |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
109,098 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,571,003 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
109,098 |
|
|
| Total
Value |
$6,571,003 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
Chief Medical Officer |
2024-04-01 |
96,304 |
2020-08-15 |
0 |
Premium* |
|
|
Sagimet Biosciences Inc. |
SGMT |
Director |
2023-07-18 |
12,794 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
50 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2020-08-17 |
4 |
AS |
$68.32 |
$12,434 |
D/D |
(182) |
0 |
0 |
% |
|
| SGMT |
Sagimet Biosciences Inc. |
Director |
– • – |
2023-07-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(8,677) |
0 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2020-08-15 |
4 |
A |
$57.43 |
$10,452 |
D/D |
182 |
182 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2020-11-10 |
4 |
D |
$60.62 |
$146,458 |
D/D |
(2,416) |
2,685 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2020-11-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,101 |
5,101 |
0 |
- |
|
| SGMT |
Sagimet Biosciences Inc. |
Director |
– • – |
2023-07-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,677 |
|
- |
|
| SGMT |
Sagimet Biosciences Inc. |
Director |
– • – |
2023-07-18 |
4 |
A |
$0.00 |
$0 |
D/D |
8,677 |
8,677 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2021-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
9,214 |
11,899 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2021-02-15 |
4 |
A |
$56.86 |
$20,696 |
D/D |
364 |
12,263 |
0 |
- |
|
| SGMT |
Sagimet Biosciences Inc. |
Director |
– • – |
2023-07-18 |
4 |
A |
$0.00 |
$0 |
D/D |
4,117 |
12,794 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2021-03-10 |
4 |
D |
$63.91 |
$104,748 |
D/D |
(1,639) |
14,079 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2021-08-15 |
4 |
A |
$55.08 |
$55 |
D/D |
1 |
14,080 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2021-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,455 |
15,718 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2021-11-10 |
4 |
D |
$67.32 |
$156,182 |
D/D |
(2,320) |
16,860 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2021-11-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,100 |
19,180 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2023-06-13 |
4 |
AS |
$76.90 |
$114,197 |
D/D |
(1,485) |
29,402 |
0 |
% |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2023-06-10 |
4 |
D |
$78.12 |
$101,087 |
D/D |
(1,294) |
30,887 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2023-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,779 |
32,181 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2022-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
20,298 |
37,158 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2022-03-10 |
4 |
D |
$57.92 |
$203,010 |
D/D |
(3,505) |
41,265 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2022-02-15 |
4 |
A |
$52.13 |
$18,141 |
D/D |
348 |
41,613 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2022-06-10 |
4 |
D |
$60.74 |
$29,459 |
D/D |
(485) |
42,167 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2022-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,039 |
42,652 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2022-09-10 |
4 |
D |
$65.28 |
$31,400 |
D/D |
(481) |
42,725 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2022-09-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,039 |
43,206 |
0 |
- |
|
50 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
